LLY

759.75

-0.52%↓

JNJ

176.59

+0.08%↑

ABBV

220.03

+1.83%↑

UNH

341.1

+0.38%↑

AZN

77.6

-0.01%↓

LLY

759.75

-0.52%↓

JNJ

176.59

+0.08%↑

ABBV

220.03

+1.83%↑

UNH

341.1

+0.38%↑

AZN

77.6

-0.01%↓

LLY

759.75

-0.52%↓

JNJ

176.59

+0.08%↑

ABBV

220.03

+1.83%↑

UNH

341.1

+0.38%↑

AZN

77.6

-0.01%↓

LLY

759.75

-0.52%↓

JNJ

176.59

+0.08%↑

ABBV

220.03

+1.83%↑

UNH

341.1

+0.38%↑

AZN

77.6

-0.01%↓

LLY

759.75

-0.52%↓

JNJ

176.59

+0.08%↑

ABBV

220.03

+1.83%↑

UNH

341.1

+0.38%↑

AZN

77.6

-0.01%↓

Kodu・Aktsiate loetelu・Novavax Inc

Search

Novavax Inc

Suletud

SektorTervishoid

8.36 -2.22

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

8.31

Max

8.77

Põhinäitajad
By Trading Economics
Sissetulek	-412M 107M
Müük	-427M 239M
P/E Sektori keskmine	3.591 35.293
Kasumimarginaal	44.519
Töötajad	952
EBITDA	-395M 121M

Soovitused
By TipRanks
Soovitused	Neutraalne
12 kuu keskmine prognoos	+16.82% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	11. nov 2025

Turustatistika
By TradingEconomics
Turukapital	219M 1.3B
Eelmine avamishind	10.58
Eelmine sulgemishind	8.36

Uudiste sentiment

By Acuity

68%

32%

332 / 371 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Strong Bullish Evidence

5.692 / 6.039 Toetus ja vastupanu

Novavax Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

2. apr 2025, 17:06 UTC

Suurimad hinnamuutused turgudel

Novavax Falls But Then Recovers After WSJ Report on Vaccine's FDA Status

31. märts 2025, 14:19 UTC

Suurimad hinnamuutused turgudel

Vaccine Stocks Fall After Ousting of FDA's Vaccine Head

4. veebr 2025, 18:52 UTC

Suurimad hinnamuutused turgudel

Psychedelic Drug Stocks Up, Vaccine Shares Down After Senate Committee Advances RFK Jr.

11. nov 2024, 14:05 UTC

Suurimad hinnamuutused turgudel

Novavax to Move Forward With Covid-19, Influenza Vaccine After FDA Lifts Clinical Hold

16. okt 2024, 12:59 UTC

Suurimad hinnamuutused turgudel

Novavax Says FDA Puts Clinical Hold on Covid-19, Flu Vaccines; Shares Drop

19. mai 2025, 14:30 UTC

Peamised uudised

Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker. -- Barrons.com

19. mai 2025, 13:27 UTC

Peamised uudised

Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker. -- Barrons.com

8. mai 2025, 17:55 UTC

Tulu

Why This Shrinking Covid-19 Vaccine Stock Jumped 30% -- Barrons.com

8. mai 2025, 15:12 UTC

Tulu

Why This Shrinking Covid-19 Vaccine Stock Jumped 30% -- Barrons.com

28. apr 2025, 17:04 UTC

Tulu

Novavax Stock Is Up Again. There Are Still Big Questions About the Fate of Its Covid Shot. -- Barrons.com

30. dets 2024, 23:02 UTC

Omandamised, ülevõtmised, äriostud

Novavax Completes Previously Announced $200M Sale of Czech Republic Manufacturing Site to Novo Nordisk

4. dets 2024, 07:09 UTC

Omandamised, ülevõtmised, äriostud

Novavax: Agreement to Close by Dec 30 >NVAX

4. dets 2024, 07:08 UTC

Omandamised, ülevõtmised, äriostud

Novavax: Sale Aligns With Plan to Become More Lean Organization, Drive Value From Pipeline Assets & Tech Platform >NVAX

4. dets 2024, 07:07 UTC

Omandamised, ülevõtmised, äriostud

Novavax: Deal to Also Reduce Annual Operating Costs by About $80M >NVAX

4. dets 2024, 07:06 UTC

Omandamised, ülevõtmised, äriostud

Novavax to Get $190M Cash Payment in 2024, Additional $10M in 2025 >NVAX

4. dets 2024, 07:06 UTC

Omandamised, ülevõtmised, äriostud

Novavax: Agreement Provides Company With Significant, Non-Dilutive Capital >NVAX

4. dets 2024, 07:04 UTC

Omandamised, ülevõtmised, äriostud

Novavax Announces Sale of Czech Republic Manufacturing Site to Novo Nordisk for $200M

15. nov 2024, 13:34 UTC

Peamised uudised

Heard on the Street: RFK Jr. Is Spooking Obesity Investors Too -- WSJ

15. nov 2024, 11:14 UTC

Market Talk

U.S. Vaccine Stocks Fall After Trump Picks Vaccine Skeptic RFK Jr as Health Department Head-- Market Talk

16. okt 2024, 15:22 UTC

Tulu

These Stocks Are Moving the Most Today: ASML, Nvidia, Morgan Stanley, United Airlines, DJT, Novavax, J.B. Hunt, Cisco, and More -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

Novavax Inc Prognoos

Hinnasiht

By TipRanks

16.82% tõus

12 kuu keskmine prognoos

Keskmine 10 USD 16.82%

Kõrge 19 USD

Madal 6 USD

Põhineb 5 Wall Streeti analüütiku instrumendi Novavax Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

5 ratings

2

Osta

1

Hoia

2

Müü

Põhineb 5 analüütiku instrumendi Novavax Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

5.692 / 6.039Toetus ja vastupanu

Recent bullish events outweigh bearish events.

All events are bearish.

Bearish events outweigh bullish events.

Sentiment

By Acuity

332 / 371 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Novavax Inc

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Muud aktsiad sektorist

LLY

Eli Lilly and Co.

759.75

JNJ

Johnson and Johnson

176.59

ABBV

AbbVie Inc

220.03

UNH

UnitedHealth Group Inc

341.1

AZN

AstraZeneca PLC ADR

77.6

Live chat